Dere Willard H 4

What Happened Dere Willard, a director of BioMarin Pharmaceutical Inc. (BMRN), received a grant of 7,490 restricted stock units (RSUs) on June 2, 2026. The Form 4 reports an acquisition code "A" (award/grant) at a $0.00 acquisition price; the filing notes the price is not applicable for RSUs. This is a compensatory equity award, not a cash purchase or sale.

Key Details

• Transaction date: June 2, 2026; Filing date: June 4, 2026 (timely under Section 16 rules).
• Transaction type/code: A (award/grant) — 7,490 RSUs; reported acquisition price $0.00 (price not applicable).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote: F1 — "Restricted stock units granted on June 2, 2026. Price not applicable."
• No indication of a 10b5-1 plan, sale, exercise, or tax-withholding event in this filing.

Context Restricted stock units are a compensation award that typically convert to shares if and when they vest; they do not represent an immediate market purchase or sale. Such director grants are common as part of board compensation and do not by themselves indicate the insider's view of the company's stock price.